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ABSTRACT 
The diagnostic deployment of massively parallel short-read next generation 
sequencing (NGS) has greatly improved genetic test availability, speed and 
diagnostic yield, particularly for rare inherited disorders. Nonetheless, 
diagnostic approaches based on short-read sequencing have a poor ability to 
accurately detect gene conversion events. We report on the genetic analysis of a 
family in which 3 fetuses had clinical features consistent with the autosomal 
recessive disorder Meckel-Gruber syndrome (MKS). Targeted NGS of 29 known 
MKS-associated genes revealed a heterozygous TMEM231 splice-donor variant 
c.929+1A>G. Comparative read-depth analysis, performed to identify a second 
pathogenic allele, revealed an apparent heterozygous deletion of TMEM231 exon 
4. To verify this result we performed single molecule long-read sequencing of a 
LR-PCR product spanning this locus. We identified 4 missense variants which 
were absent from the short-read dataset due to the preferential mapping of 
variant-containing reads to a downstream TMEM231 pseudogene. Consistent 
with the parental segregation analysis, we demonstrate that the single-molecule 
long reads could be used to show that the variants are arranged in trans. Our 
experience shows that robust validation of apparent dosage variants remains 
essential to avoid the pitfalls of short-read sequencing, and that new third-
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generation long-read sequencing technologies can already aid routine clinical 
care. 
Keywords: 
Meckel-Gruber syndrome, TMEM231, gene conversion, nanopore sequencing 
INTRODUCTION 
The molecular diagnosis of rare genetic conditions has been revolutionised by 
the widespread adoption of short-read next generation sequencing (NGS). For 
urgent diagnosis (for example in paediatric intensive care units), it is now 
possible to perform whole genome sequencing in under two weeks (Mestek-
Boukhibar et al., 2018). Nonetheless, most routine diagnostic analyses still focus 
on a subset of the genome; typically using a range of hybridisation capture 
reagents that enable enrichment of the coding and immediate flanking intronic 
sequences of disease-associated genes. For genetically heterogeneous disorders, 
the ability to concurrently sequence multiple disease genes, using a single 
reagent, has overcome the need to perform consecutive single-gene tests, and 
has thereby greatly improved the overall efficiency of testing pathways. 
Although targeted gene capture panels remain popular, an increasingly 
hypothesis-free approach to gene selection means that testing is no longer 
predicated entirely on accurate clinical diagnosis. This is reducing the effects of 
ascertainment biases reported in the medical literature, and allowing refinement 
of the mutation spectrum for many disorders. In this way, the genotype-
phenotype relationships for syndromes that have overlapping diagnostic 
features are being clarified. Two such conditions with considerable underlying 
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genetic heterogeneity are Joubert (JBTS; MIM# 213300) and Meckel-Gruber 
(MKS; MIM# 249000) syndromes, which are ciliopathies associated with 
causative mutations in at least 27 and 17 genes respectively, 12 of which are 
reported to cause both conditions (Hartill et al., 2017). JBTS is characterised by a 
characteristic neuroradiological finding (the molar tooth sign) in conjunction 
with neurodevelopmental abnormalities, notably hypotonia and ataxia. There 
are frequently abnormalities of oculomotor function and breathing pattern, as 
well as a wide spectrum of associated features, including polydactyly, retinal 
dystrophy, renal disease and hepatic fibrosis. Although some children die in 
infancy, most survive, with varying developmental outcomes. MKS is a more 
severe perinatally lethal syndrome that is characterised by posterior cranial 
fossa abnormalities (typically occipital encephalocele), postaxial polydactyly, 
bilateral enlarged cystic kidneys and hepatic ductal plate malformation. Because 
of the genetic and phenotypic overlap between the two disorders, like most 
laboratories, we routinely deploy a gene panel diagnostic approach that 
examines all JBTS- or MKS-associated disease genes, irrespective of which of the 
two diagnostic categories the clinical features suggest. 
The overwhelming majority of diagnostic NGS data is generated using 
sequencing-by-synthesis chemistry on instruments manufactured by Illumina. 
Although this method yields reads with high per-base consensus accuracy, the 
relatively short individual read length can prevent unambiguous mapping to the 
genomic reference sequence. Targets disproportionately affected by this 
limitation include families of gene and pseudogene homologs (Ebbert et al., 
2019). Other genomic regions are intractable to analysis due to difficulties 
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caused by the sequencing chemistry itself. These include regions of high GC 
content, which are difficult to amplify. Third-generation single-molecule 
sequencers promise to overcome some of these limitations by generating long 
sequencing reads (spanning multiple kilobases) and enabling targeted library 
preparation without a requirement for PCR amplification. 
Here, we describe the use of third-generation methods to resolve an 
anomalous diagnostic result stemming directly from limitations inherent to the 
automated short-read pipeline approach. In a fetal sample referred for molecular 
genetic analysis of MKS, targeted variant screening identified a likely pathogenic 
TMEM231 splice site mutation c.929+1A>G and an apparent heterozygous 
deletion of TMEM231 exon 4. However, validation of the apparent deletion-
containing allele, performed using single-molecule nanopore sequencing, 
revealed a gene conversion event (introducing 4 missense variants). This result 
had been masked from the short-read dataset due to the preferential mapping of 
gene conversion-containing reads to the downstream pseudogene. 
MATERIALS AND METHODS 
Consultant clinical geneticists reviewed post-mortem reports on the deceased 
subjects. Ethical approval for this study was given by the Leeds East Research 
Ethics Committee (18/YH/0070). 
DNA was isolated using phenol/chloroform or bead-based extraction methods, 
following informed written consent. A custom SureSelect hybridisation 
enrichment reagent was used to create an Illumina-compatible sequencing 
library following manufacturers protocols (Agilent Technologies, Wokingham, 
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UK). The probe set targeted coding sequences and immediate flanking intronic 
regions of 223 genes implicated in paediatric neurological disorders, of which 29 
were associated with Meckel-Gruber or Joubert syndromes (see Supp. Data File 
1). Eight such libraries were pooled in equimolar concentrations to create a 
batch which was combined with two other similar library batches and then 
sequenced on a NextSeq500 to produce paired-end 151-bp reads from a high-
output cartridge (Illumina, San Diego, CA, USA). 
Data processing was performed using a standard informatics pipeline. Raw data 
were converted from BCL to FASTQ.gz format using bcl2fastq (v.2.17.1.14). 
Adaptor sequences and low-quality bases (-q 10) were removed from reads 
using Cutadapt (v.1.9.1) (https://cutadapt.readthedocs.org) (Martin 2011) prior 
to alignment to an indexed human reference genome (hg19) using BWA MEM 
(v.0.7.13) (http://bio-bwa.sourceforge.net) (Li and Durbin, 2009). File 
manipulations, including sam-to-bam conversion, duplicate removal and bam file 
indexing, were performed using Picard (v.2.1.1) 
(http://broadinstitute.github.io/picard). Assembly-based realignment was 
performed at hybridisation capture target sites using ABRA2 v.0.03 
(https://github.com/mozack/abra2) (Mose et al., 2014). The Genome Analysis 
Toolkit (GATK) (v.2.3-4Lite) was used to perform indel realignment, base quality 
score recalibration and variant calling, following the GATK best practice 
workflow (https://software.broadinstitute.org/gatk/) (DePristo et al., 2011). 
Each variant was annotated using Alamut Batch standalone (v.1.5.2; database 
version 2016.09.27) (Interactive Biosoftware, Rouen, France) before its clinical 
significance was assessed according to the Association for Clinical Genomic 
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Science best practice guidelines (Ellard et al., 2018). An in-house comparative 
read-depth method was performed to identify dosage variants. Normalised read 
counts for the control group were generated from corresponding intra-batch 
patient libraries. The number of reads mapping to each target base was assessed 
using the GATK walkers DepthOfCoverage, CallableLoci and CountReads. Aligned 
sequence reads were manually inspected using the Integrative Genome Viewer 
(v.2.4.10) (http://software.broadinstitute.org/software/igv/) (Thorvaldsdóttir 
et al., 2013). Reported variants have been deposited in LOVD3 
(http://www.lovd.nl). 
To characterise an apparent TMEM231 heterozygous exon 4 deletion 
(NM_001077416.2), a 6163-bp long-range PCR amplicon was sequenced using a 
MinION long-read sequencer (ONT: Oxford Nanopore Technologies, Oxford, UK). 
Each PCR reaction consisted of 1 µL of genomic DNA (~50 ng/µL), 14.24 µL of 
nuclease-free H2O, 2 µL of 10 × SequalPrepTM reaction buffer (Invitrogen, Paisley, 
UK), 0.36 µL of 5 U/µL SequalPrepTM long polymerase (Invitrogen), 0.4 µL of 
DMSO (Invitrogen), 1µL of 10 × SequalPrepTM Enhancer A (Invitrogen), and 0.5 
µL each of 10 pmol/µL forward 
(dCAGGAAACAGCTATGACCACCACCTGATTCTGAAACACG) and reverse 
(dTGTAAAACGACGGCCAGTGCCAGTGAACATTTGAAAGGC) primers. 
Oligonucleotides were purchased from Thermo Fisher Scientific (Waltham, MA, 
USA). Thermocycling conditions are recorded in Supp. Table S1. Both primers 
contained universal sequencing tags (underlined) to enable confirmation of 
amplicon specificity by Sanger sequencing on an ABI3730, following 
manufacturers protocols (Applied Biosystems, Paisley, UK). Amplification 
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products were subsequently resolved on a 1% tris-borate EDTA agarose gel, 
before being extracted and purified using a QIAquick column (Qiagen GmbH, 
Hilden, Germany). To create a MinION-compatible sequencing library, an end-
repair and nickase treatment reaction was first performed. The reaction 
consisted of 3.5 µL UltraTM II end prep reaction buffer (New England Biolabs, 
Ipswich, MA, USA), 3.5 µL FFPE DNA repair buffer (New England Biolabs), 3.0 µL 
UltraTM II end prep enzyme mix (New England Biolabs), 2.0 µL FFPE DNA repair 
mix (New England Biolabs), 32.4 µL nuclease-free H2O and 15.6 µL (1.5 µg) of 
the gel-extracted 6.2-kb PCR product (95.9 ng/µL). The reaction was incubated 
at 20Ԩ for 5 minutes then 65Ԩ for 5 minutes. Following an AMPure XP bead 
clean-up reaction (Beckman Coulter, Indianapolis, IN, USA), sequencing adaptors 
were ligated to the termini of double-stranded DNA. The reaction comprised 60 
µL of PCR products, 25 µL of LNB (ONT), 10 µL of Quick Ligase (New England 
Biolabs) and 5 µL of AMX (ONT) and was incubated at room temperature for 10 
minutes. A further AMPure XP bead clean-up was performed, using SFB (ONT) to 
wash the beads, and 15 µL of EB (ONT) to elute the sample. A MinION FLO-
MIN106 Rev D flowcell was prepared for loading. Briefly, 30 µL of FLT (ONT) 
was combined with a vial of FLB (ONT) to create a flowcell priming mix, from 
which 800 µL was loaded through the flowcell priming port. The eluted library 
(12 µL) was combined with 37.5 µL of SQB (ONT) and 25.5 µL of LB (ONT), then 
loaded into the flowcell through the SpotON port. A 48-hour MinION sequencing 
run was initiated using MinKNOW software (v.3.1.13) (ONT). 
Offline basecalling was performed using Guppy (v.2.1.3) to convert raw data 
from fast5 to FASTQ format (http://nanoporetech.com). Adaptor sequences 
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were trimmed from the resulting reads using Porechop (v.0.2.3) 
(https://github.com/rrwick/Porechop) before NanoFilt (v.2.2.0) 
(https://github.com/wdecoster/nanofilt) removed low-quality reads (-q 4) (De 
Coster et al., 2018). Alignment to the human reference genome (build hg19) was 
performed using minimap2 (v.2.10) (https://github.com/lh3/minimap2) (Li, 
2018). In view of the excessive read depth generated from the full dataset (mean 
coverage of 1.19 million ×), raw data were down-sampled to comprise only the 
first 20 fast5 files produced by the MinION (corresponding to 80,000 reads). 
Summary sequencing metrics are recorded in Supp. Table S2. Variant calling was 
performed using NanoPolish (v.0.11.0) (https://nanopolish.readthedocs.io) to 
generate a VCF file, used in combination with WhatsHap (v.0.17) 
(https://whatshap.readthedocs.io/) (Martin et al., 2016) to group individual 
reads based on their variant-defined haplotype. Sam-to-bam file conversion, read 
sorting and bam file indexing was performed using samtools (v.1.8) (Li et al., 
2009). Read metrics were generated using NanoStat (v.1.1.0) 
(https://github.com/wdecoster/nanostat) (De Coster et al., 2018). 
To confirm and genotype the TMEM231 intron 3/exon 4 gene conversion, a 
1,187-bp amplicon (based on the assay reported in Maglic et al., 2016) was 
optimised for use with our routine diagnostic Sanger sequencing workflow (as 
previously described). Each PCR comprised 0.5 µL of genomic DNA (~50 ng/µL), 
14.1 µL of Megamix (Microzone Ltd, Haywards Heath, UK), 0.2 µL of 10 pmol/µL 
forward primer (dCAGGAAACAGCTATGACCTGACTACGGCCTTGAACTCA) and 0.2 
µL of 10 pmol/µL reverse primer 
(dTGTAAAACGACGGCCAGTGTAACACTGTAGATGCTTTTAG). Thermocycling 
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conditions are recorded in Supp. Table S3. An internal sequencing primer 
(dCCTTGAAAGTCCTGAGCAGC) was used to generate the Sanger sequencing 
chromatograms. To confirm and validate the TMEM231 intron 5 
(NM_001077416.2) splicing variant, a 517-bp amplicon was optimised for 
Sanger sequencing. Each reaction consisted of 0.5 µL of genomic DNA (~50 
ng/µL), 11.3 µL of Megamix, 0.1 µL of 10 pmol/µL forward primer 
(dTGTAAAACGACGGCCAGTTGCTTTAAGAGGCAGGGTCT) and 0.1 µL of 10 
pmol/µL reverse primer 
(dCAGGAAACAGCTATGACCGCCAGAGTCAAACAGCCATC). Thermocycling 
conditions are recorded in Supp. Table S3. Chromatograms from all Sanger 
sequencing reactions were analysed using 4Peaks software (v.1.8) 
(http://nucleobytes.com/4peaks/index.html). 
RESULTS 
DNA from a male fetus of Scottish origin was referred for molecular genetic 
testing of 29 Meckel-Gruber and Joubert syndrome-associated disease genes. The 
pregnancy had been terminated in the thirteenth week of gestation, following 
identification of enlarged multicystic dysplastic kidneys and occipital 
encephalocoele. Additional post-mortem findings included hepatic ductal plate 
malformation and postaxial polydactyly of both hands. Other dysmorphic 
features, including small low set ears, a wide neck with broad shoulders and 
bilateral talipes equinovarus, were also noted. The kidneys were of increased 
weight and brain weight was markedly reduced. Two previous abnormal 
pregnancies were also recorded; in the first, the fetus had occipital 
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encephalocoele and bilateral enlarged cystic kidneys, and the second ended in a 
first trimester miscarriage. 
Two possibly relevant DNA sequence variants were initially identified, and their 
clinical significance was interpreted according to criteria recommended by the 
Association for Clinical Genomic Science (Ellard et al., 2018). The first of these 
was the heterozygous variant KIAA0586 c.4589-6A>C (NM_001244189.1). 
Standard in silico tools suggested that this variant was unlikely to be pathogenic 
and did not provide an explanation for the presenting clinical features. The 
second variant, TMEM231 (c.929+1A>G) (NM_001077416.2), which was 
heterozygous and located at the intron 5 splice donor site, was classified as likely 
pathogenic. This variant had not been previously reported on ClinVar 
(https://www.ncbi.nlm.nih.gov/clinvar/) or the LOVD3 TMEM231 gene-specific 
variant database (https://databases.lovd.nl/shared/variants/TMEM231). 
Consistent with a rare recessive inheritance pattern, there were only two 
recorded observations of this sequence variant in the gnomAD v.2.1 dataset 
(among 244,308 total alleles), and these had been identified in separate 
individuals (Lek et al., 2016). The zygosity and segregation of the c.929+1A>G 
variant were confirmed by Sanger sequencing; the probands mother was 
determined to be a heterozygous carrier (Supp. Figure S1). 
We subsequently performed copy number analysis, using a comparative read 
depth method, in an attempt to identify a second pathogenic allele that would 
confirm a molecular diagnosis of Meckel-Gruber syndrome. These data revealed 
an apparent TMEM231 exon 4 deletion (NM_001077416.2), with a dosage 
quotient (0.63) suggestive of a heterozygous deletion (Supp. Figure S2A). To 
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verify and better delineate this observation, a 6.2-kb long-range PCR amplicon 
across the region was generated. We opted to sequence this using a long-read 
single-molecule sequencer (Oxford Nanopore MinION), because the two alleles 
could not be resolved on agarose gel electrophoresis for conventional Sanger 
sequencing. The expected exon 4 deletion could not be validated by this analysis, 
but we instead observed four clustered substitution variants (c.742-1G>A, 
c.742A>G, c.747C>T and c.752T>C) that were present in the long-read, but not 
the short-read, datasets (Figure 1). The same clustered variants have previously 
been observed and attributed to a gene conversion event occurring between 
TMEM231 and a pseudogene located approximately 40 kb downstream 
(centromeric) from the functional gene (Maglic et al., 2016). It therefore 
appeared that during alignment, reassignment of short reads containing 
pseudogene-derived variants, from TMEM231 to the more closely-matching 
pseudogene locus, was the explanation for the apparent loss of read depth at 
exon 4. We confirmed the presence of the conversion event by Sanger 
sequencing a 1187-bp amplicon derived from the gene-specific intron 3/exon 4 
locus, and showed that it was paternally inherited (Figure 2A). Two flanking 
pseudogene-derived variants (c.742-49G>A and c.823+4A>G) reported by Maglic 
et al. (2016) were not detected on the converted allele in our patient (data not 
shown); suggesting that the allele we have observed reflects a recurrent gene 
conversion event, rather than an ancestral founder allele. 
To assess the relative number of copies of the TMEM231 exon 4 pseudogene, we 
performed comparative read depth analysis across the corresponding 
downstream pseudogene region. We calculated a normalised dosage quotient of 
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1.20, suggestive of a total of 3 copies of the pseudogene exon (Supp. Figure S2). 
We determined that short-read sequences that mapped to TMEM231 pseudogene 
exon 4 (chr16:75,536,434-75,536,515) have a mean MAPQ value of 54, 
indicating high alignment specificity. 
To further demonstrate the clinical utility of long-read sequencing, we 
performed variant calling across the long-range PCR amplicon and used the 
resulting genotypes to group reads according to their likely haplotype (Figure 
2B). These data were consistent with the pathogenic TMEM231 variants being 
arranged in trans; an observation that was consistent with the parental 
inheritance studies. DNA samples were not available for testing from the 
previous two affected pregnancies, but given the clinical similarities and the 
genetic findings above, it seems highly likely that they too were compound 
heterozygous for the intron 5 splice donor mutation and the exon 4 gene 
conversion. 
By using the apparent TMEM231 exon 4 deletion as a surrogate marker for the 
gene conversion allele, we retrospectively analysed 45 cases referred for 
JBTS/MKS testing, and 377 cases referred for analysis of non-JBTS/MKS 
associated gene (but sequenced using the same hybridisation capture reagent). 
We were unable to identify any further gene conversion alleles, suggesting that 
their population frequency is less than 1/844. 
DISCUSSION 
NGS workflows that target curated lists of disease-associated genes are now 
deeply embedded into routine practice. For some heterogeneous conditions 
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(such as the Meckel-Gruber/Joubert spectrum of ciliopathies discussed here) 
there remains debate concerning the set of genes that should be analysed. For 
practicality, many laboratories rely on hybridisation capture to enable 
enrichment of target loci, but capture reagents frequently become outdated as 
gene lists and reported mutation spectra expand. Whole genome sequencing has 
the potential to circumvent these limitations, and its introduction into routine 
practice has now begun (Turnbull et al., 2018). Irrespective of these different 
approaches, though, the overwhelming majority of NGS-based diagnoses are 
based on short-read Illumina technology, for which there are well-documented 
limitations (van Dijk et al., 2018). In recent years, in contrast, the use of third-
generation long-read sequencers has significantly increased our knowledge of 
genetic variation, particularly with respect to the frequency and complexity of 
structural variants (Huddleston and Eichler, 2016). 
We routinely supplement our diagnostic variant calling with comparative read-
depth analyses. Although it is recognised that the sensitivity of this varies across 
different target loci (due to factors such as GC content affecting capture 
efficiency) false positive deletion-containing variants are rarely identified. This 
led us to query our inability to validate an apparent TMEM231 exon 4 deletion. 
The finding that four variants were present in the long-read (but not the short-
read) dataset alerted us to the presence of a previously-reported gene 
conversion event involving a downstream TMEM231 pseudogene (Maglic et al., 
2016). The implicated source exon contains pseudogene-specific variants, and 
these result in loss of TMEM231 function (as a result of aberrant splicing) 
following the gene conversion.  
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When alignment to the reference genome is performed, the variants introduced 
at the functional locus by gene conversion direct alignment of the short reads to 
the corresponding pseudogene locus. This has two effects: it hides the 
existence of these sequence variants (from both automated variant callers and 
manual interrogation by genome analysts) and reduces the apparent read depth 
over the target exon, mimicking a deletion. It may be noted that while it is not 
uncommon to encounter reads mapping to pseudogene sequences, the analyst is 
typically alerted to such loci when read alignment metrics (defined by the MAPQ 
score) are reduced 0; this was not the case here. 
From a molecular diagnostic perspective, we have previously discussed how the 
technical limitations of existing NGS workflows can be ascertained by further 
investigating patients in whom only a single pathogenic variant is initially 
discovered (Watson et al., 2016). Although mutations in TMEM231 have thus far 
reportedly accounted for only a limited proportion of the MKS mutation 
spectrum (Hartill et al., (2017) it remains unclear how many patients have been 
identified with only a single pathogenic variant and in whom a second 
pathogenic variant, if present, remains refractory to analysis. To our knowledge, 
this is the second report of a TMEM231 exon 4 gene conversion, and our 
observation that the c.742-49G>A and c.823+4A>G pseudogene-specific variants 
are absent from the gene-conversion allele, suggest that this mutation is 
recurrent, rather than ancestral, in origin. Further characterisation of the gene-
specific and pseudogene loci, to define the minimum and maximum extent of the 
gene conversion event, was not possible, due to limited biological material. 
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The recognition of recurrent TMEM231 gene conversion events leads us to 
recommend that such events should be ruled out in all cases for whom a single 
pathogenic mutation has thus far been identified. In view of the route by which 
we identified the gene conversion event, we suggest that laboratories 
performing comparative read-depth analysis of TMEM231 exon 4 also assess the 
relative dosage of the corresponding pseudogene exon (chr16:75,536,434-
75,536,515). Despite this recommendation, it remains unclear how neutral 
polymorphisms affecting the functional gene, or pseudogene-specific variants 
that are not represented in existing reference assemblies (but may be frequent 
and as-yet uncharacterised in the general population), would affect the 
sensitivity of this approach. 
A critical long-standing consideration, when undertaking PCR-based 
amplification of loci known to have pseudogene counterparts, has been the 
specificity of amplification primers. With the advent of third generation 
sequencing, this concern may, to a greater or lesser extent, be alleviated by 
accurate mapping of long-read sequences from a mixed pool of functional and 
pseudogene-derived amplification products. The extent to which this will work is 
likely to depend on both the achieved read length and the sequence divergence 
between gene and pseudogene; this will be unpredictable in the context of the 
whole genome, and require locus-by-locus assessment. Fortunately, the 
possibility of performing PCR-free target enrichment and long-read sequencing, 
from bulk genomic DNA (Gabrieli et al., 2018), may eventually obviate this 
question of primer specificity entirely. 
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Our ability to determine phase information directly, showing that the pathogenic 
variants were on opposite parental alleles, highlights a further advantage of 
long-read sequencing. This capability is likely to prove crucial whenever it is not 
possible to undertake parental segregation studies. Additional technological 
advances, in direct and synthetic long-read sequencing, present possibilities for 
creating contiguous haplotypes linking gene-specific regions to their pseudogene 
counterparts; this could enable more precise characterisation of the minimal and 
maximal extents of identified gene conversion events. However, the requirement 
for high-molecular weight DNA must be borne in mind for future diagnostic 
work-flows, and may prove to be a significant challenge, particularly in the 
analysis of degraded fetal tissue or very small diagnostic biopsies. 
Finally, this report also cautions that dosage variants identified by comparative 
read-depth methods should always be validated by another method. Aside from 
the quality assurance provided by this approach, precise characterisation of 
clinically relevant structural variants often allows the creation of facile 
diagnostic tests that can be used for extended family testing (Watson et al., 
2014). 
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FIGURES 
Figure 1: A representative comparison of read alignments between the short-read 
NextSeq and long-read MinION datasets. Reads identifying the gene conversion event 
(containing four non-reference nucleotides) were not visible in in short-read data. The y-axis 
scale for each cumulative read-depth plot is labelled. Non-reference bases with a minor 
allele fraction exceeding 0.35 are highlighted. Non-reference bases in variant-containing 
reads are coloured with respect to the sense strand (T: red, C: blue, A: green and G: brown). 
The IGV’s “quick-consensus mode” is enabled. TMEM231 is encoded on the antisense 
strand. Sense strand nucleotides are shaded grey. 
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Figure 2: (A) Sanger sequencing chromatograms confirmed the intron 3/exon 4 gene 
conversion in the proband and established paternal inheritance. A “*”  denotes each of the 
four variants (c.742-1G>A, c.742A>G, c.747C>T and c.752T>C) that characterise the gene 
conversion event. Intron 3 sequence is displayed in lowercase and shaded grey. Exon 4 
sequence is displayed in uppercase with orange highlighting. Numbering is according to 
transcript NM_001077416.2. Chromatograms have been reverse-complemented to aid their 
interpretation in the context of the TMEM231 gene sequence, which is encoded on the 
antisense strand. (B) Long-read sequencing demonstrated that that the heterozygous gene 
conversion and c.929+1A>G mutations (red boxes) are arranged in trans on separate 
parental haplotypes. To aid visualisation, 1% of the analysed reads were displayed using the 
IGV’s “quick consensus mode”. The y-axis scale for each cumulative read-depth plot is 
labelled. 
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